Scientists develop 'world first' melanoma blood test
Australian researchers said Wednesday they have developed a blood test for melanoma in its early stages, calling it a "world first" breakthrough that could save many lives.
Jul 18, 2018
0
1626
Australian researchers said Wednesday they have developed a blood test for melanoma in its early stages, calling it a "world first" breakthrough that could save many lives.
Jul 18, 2018
0
1626
Skin cancer is the number-one cancer diagnosis in the United States – it's more common than breast, prostate, and lung cancers combined. Skin cancers can be divided into two types – nonmelanoma (basal and squamous cell ...
Jul 4, 2018
0
7
Squamous cell carcinoma is the second-most-common form of skin cancer. Evidence suggests the human papilloma virus plays a role in the development of some types of this skin cancer.
Jul 3, 2018
0
3
New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center.
Jul 2, 2018
0
29
University of Queensland researchers have discovered how to reverse drug resistance in skin and mouth squamous cell carcinomas.
Jun 28, 2018
0
85
Oral squamous cell carcinomas (OSCCs) are the most common head and neck cancers, but are often diagnosed late.
Jun 26, 2018
0
6
(HealthDay)—If you could protect yourself from cancer, you'd do it, right? Yet most Americans still aren't taking the easiest step to prevent the most commonly diagnosed type—skin cancer, which will affect one in five ...
Jun 15, 2018
0
0
Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of a common skin cancer, an international team led by a researcher at The University ...
Jun 4, 2018
0
4
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies ...
May 10, 2018
0
12
(HealthDay)—Type 2 diabetes is independently associated with a greater risk of renal cell carcinoma (RCC) in women, but not in men, according to a study published online April 20 in Diabetes Care.
May 8, 2018
0
4